You are here

CNS

Jupiter Neurosciences Makes Way in CNS Treatments with $11M IPO

Xtalks

Wed, 12/4/24 - 11:09 pm

Jupiter Neurosciences

Brain drug developer Alto Neuroscience prices $129M IPO

BioPharma Dive

Fri, 02/2/24 - 11:39 am

Alto Neuroscience

Sanofi Sells 11 CNS Assets to Pharmanovia including Frisium and Gardenal

BioSpace

Tue, 09/19/23 - 10:53 am

Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab

Fierce Biotech

Mon, 01/9/23 - 10:34 am

Voyager Therapeutics

Parkinson's Disease

CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Targeting Platform and Advance Lead Programs into the Clinic

Businesswire

Wed, 07/20/22 - 09:36 am

Dravet syndrome

Sanofi offloads 17 brands to Neuraxpharm

Fierce Pharma

Tue, 07/12/22 - 10:57 am

SciNeuro Pharmaceuticals Announces a License and Option Agreement with GSK to Progress Development of Novel Therapies for CNS Diseases

BioSpace

Wed, 06/1/22 - 09:46 am

Alzheimer's disease

Sanofi Strikes Deal With Mysterious Psychedelics Biotech Terran

BioSpace

Thu, 04/21/22 - 11:27 pm

Terran Biosciences

psychedelic drugs

Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets

BioSpace

Thu, 04/21/22 - 10:54 am

Terran Biosciences

Chasing Bristol Myers and Biogen/Denali, CNS biotech raises $100M in dash toward clinic

Endpoints

Wed, 03/30/22 - 10:35 am

Bristol Myers Squibb

With a make-or-break PhIII readout looming, a struggling Concert offloads a 'portfolio' of drugs

Endpoints

Mon, 03/14/22 - 10:31 am

Concert Pharmaceuticals

Terran Biosciences

Digging into biopharma’s big buyout areas

EP Vantage

Fri, 03/11/22 - 10:26 am

IACT LMC Manna Research Merges with True North Clinical Research, Boosting the Network’s Central Nervous System Disorder Capabilities

CP WIre

Mon, 12/20/21 - 12:30 pm

True North Clinical Research

IACT LMC Manna Research

Lundbeck taps Inscopix’ brain-mapping camera tech for CNS research

Pharmaforum

Mon, 09/20/21 - 10:59 pm

Takeda fleshes out CNS pact with peptide drugmaker, setting aside $3.5B in future milestones

Endpoints

Tue, 07/27/21 - 10:31 am

In quick start to new year's M&A, Arvelle Therapeutics hands reins to Angelini as it nears EU approval for cenobamate

Endpoints

Mon, 01/4/21 - 10:41 am

Arvelle Therapeutics

Angelini Pharma

Dyno, Roche to tackle CNS, liver disease in gene therapy deal worth up to $1.8B

Fierce Biotech

Wed, 10/14/20 - 10:49 am

Spark Therapeutics

Cyclerion fails sickle cell test, prompting pivot to CNS disease

Fierce Biotech

Wed, 10/14/20 - 10:46 am

sickle cell disease

Evox’s exosome platform draws Lilly in potential $1.2B CNS deal

BioWorld

Tue, 06/9/20 - 11:09 am

Evox Therapeutics

Taysha Launches With $30M to Bring Gene Therapy to CNS Disorders

Xconomy

Wed, 04/29/20 - 10:47 am

Pages